Palo Alto Investors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Palo Alto Investors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-855,713	Closed	-$17.3M	–	44
2021 Q3	$17.3M	Buy	855,713 +523,000	+157%	+$14.4M	1.04%	21
2021 Q2	$12.4M	Hold	332,713	–	–	0.68%	22
2021 Q1	$8.51M	Buy	332,713 +900	+0.3%	+$23K	0.48%	24
2020 Q4	$7.31M	Hold	331,813	–	–	0.38%	22
2020 Q3	$5.97M	Hold	331,813	–	–	0.33%	23
2020 Q2	$8.43M	Hold	331,813	–	–	0.51%	21
2020 Q1	$6.09M	Hold	331,813	–	–	0.51%	23
2019 Q4	$7.31M	Hold	331,813	–	–	0.4%	23
2019 Q3	$4.76M	Hold	331,813	–	–	0.32%	25
2019 Q2	$5.23M	Sell	331,813 -169,100	-34%	-$2.3M	0.25%	28
2019 Q1	$7.34M	Hold	500,913	–	–	0.31%	28
2018 Q4	$5.36M	Hold	500,913	–	–	0.29%	28
2018 Q3	$7.64M	Hold	500,913	–	–	0.31%	27
2018 Q2	$6.14M	Hold	500,913	–	–	0.25%	27
2018 Q1	$4.79M	Hold	500,913	–	–	0.2%	27
2017 Q4	$4.52M	Hold	500,913	–	–	0.19%	28
2017 Q3	$2.88M	Hold	500,913	–	–	0.12%	29
2017 Q2	$1.59M	Buy	500,913 +19,394	+4%	+$61.2K	0.07%	29
2017 Q1	$1.64M	Buy	481,519 +323,240	+204%	+$910K	0.08%	29
2016 Q4	$456K	Sell	158,279 -109,611	-41%	-$390K	0.03%	37
2016 Q3	$1.57M	Hold	267,890	–	–	0.09%	33
2016 Q2	$804K	Hold	267,890	–	–	0.06%	40
2016 Q1	$1.44M	Hold	267,890	–	–	0.11%	36
2015 Q4	$3.18M	Hold	267,890	–	–	0.18%	33
2015 Q3	$2.2M	Buy	267,890 +197,184	+279%	+$2.28M	0.11%	36
2015 Q2	$986K	Buy	+70,706	New	+$1.3M	0.04%	42

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Palo Alto Investors's DRNA Position: Q4 2021 in Review

Palo Alto Investors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 855,713 shares — an estimated $17.3M sold.

Palo Alto Investors first reported a position in DRNA in Q2 2015 and held it in 26 quarters. The position peaked at $17.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Palo Alto Investors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Palo Alto Investors sold 855,713 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $17.3M.
Palo Alto Investors first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 26 quarters.
Palo Alto Investors's Dicerna Pharmaceuticals, Inc. position peaked at $17.3M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Palo Alto Investors's 13F filing for Q4 2021, filed 14 Feb 2022.